Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
Bacillus Calmette-Guérin (BCG)PDL

Including but not limited to Bacillus Calmette-Guérin (BCG), Strain TICE, when sold or recommended as an antineoplastic agent.

I NOV / 19
Bacillus Calmette-Guérin (BCG) vaccine I FEB / 02
Bacitracin or its salts or derivativesPDL

For veterinary use

I DEC / 18
Bacitracin or its salts or derivatives .

For human use: for parenteral use

I SEP / 98
Bacitracin or its salts or derivatives ..

For human use: for topical use

U SEP / 98
Bacitracin or its salts or derivatives …

For human use: for ophthalmic use

III JUN / 06
Baclofen or its saltsPDL I DEC / 13
Baloxavir marboxilPDL I JUL / 20
Bambuterol or its saltsPDL I DEC / 13
BamlanivimabPDL I NOV / 20
Barbiturates, their salts and derivativesC

Excluding the substances set out in items 6 and 7 of Part I of this schedule (Schedule G of the Food and Drug Regulations), as well as barbituric acid and its salts and 1,3-dimethylbarbituric acid and its salts, but including: Allobarbital; Alphenal; Amobarbital; Aprobarbital; Barbital; Butabarbital; Butalbital; Butallylonal; Butethal; Cyclobarbital; Cyclopal; Heptabarbital; Hexethal; Hexobarbital; Mephobarbital; Methabarbital; Methylphenobarbital; Propallylonal;
Phenobarbital; Probarbital; Phenylmethylbarbituric Acid; Sigmodal; Talbutal; Vinbarbital; Vinylbital
 

I JUN / 02
Baricitinib or its saltsPDL I OCT / 18
BasiliximabPDL I DEC / 13
Bazedoxifene or its saltsPDL I DEC / 14
BecaplerminPDL I DEC / 13
BelimumabPDL I DEC / 13
Belladonna alkaloids, and their salts and derivatives except in preparations for topical use or in trace amounts in homeopathic preparations II SEP / 98
BemegridePDL I DEC / 13
Benactyzine or its saltsPDL I DEC / 13
Benazepril or its salts or derivativesPDL

including but not limited to benazepril hydrochloride

I DEC / 13
Bendamustine or its salts or derivativesPDL

including but not limited to bendamustine hydrochloride

I DEC / 13
Bendazac or its saltsPDL I DEC / 13
Benoxaprofen or its saltsPDL I DEC / 13
Benoxinate hydrochloride oxybuprocaine for ophthalmic or parenteral use II SEP / 98
BenralizumabPDL I MAY / 18
Benserazide or its saltsPDL I DEC / 13
Bentiromide II SEP / 98
Benzalkonium and its salts liquid preparations in concentrations of more than 2% II SEP / 98
Benzazocines, their salts, derivatives and salts of derivativesN

Including: Phenazocine, Metazocine, Pentazocine; but not including: Cyclazocine and its salts
 

I JUN / 02
Benzethonium chloride liquid preparations in concentrations of more than 1% II SEP / 98
Benzimidazoles, their salts, derivatives and salts of derivativesN

Including: Clonitazene, Etonitazene 
 

I JUN / 02
Benzocaine and its salts for parenteral or ophthalmic use II SEP / 98
Benzodiazepines, their salts and derivativesTS

Including: Alprazolam, Bromazepam, Brotizolam, Camazepam, Chlordiazepoxide, Clobazam, Clonazepam, Clorazepate, Cloxazolam, Delorazepam, Diazepam, Estazolam, Ethyl Loflazepate, Fludiazepam, Flurazepam, Halazepam, Haloxazolam, Ketazolam, Loprazolam, Lorazepam, Lormetazepam, Medazepam, Midazolam, Nimetazepam, Nitrazepam, Nordazepam, Oxazepam, Oxazolam, Pinazepam, Prazepam, Quazepam, Temazepam, Tetrazepam,  Triazolam; but not including: Clozapine and any salt thereof, Flunitrazepam and any salts or derivatives thereof, Olanzapine and its salts, Clozapine N-oxide and its salts

I SEP / 98
Benzonatate III SEP / 98
Benzoyl peroxidePDL

in concentrations greater than 5% or when sold in combination with another medicinal ingredient

I DEC / 13
Benzoyl peroxide. preparations of 5% or less as a single ingredient U MAY / 08
Benztropine or its saltsPDL

including but not limited to benzatropine

I DEC / 13
Benzydamine or its saltsPDL I DEC / 13
Benzyl benzoate II SEP / 98
Bepotastine or its salts or derivativesPDL I NOV / 16
BeractantPDL I DEC / 13
Besifloxacin or its saltsPDL I DEC / 13
Betahistine or its saltsPDL I DEC / 13
Betaine or its saltsPDL

for human use, when sold or recommended for the treatment of homocystinuria

I DEC / 13
Betaine or its salts.PDL

for veterinary use

I DEC / 13
Betaxolol or its saltsPDL I DEC / 13
Bethanechol chloridePDL I DEC / 13
Bethanidine or its saltsPDL I DEC / 13
BevacizumabPDL I DEC / 13
Bezafibrate or its salts or derivativesPDL I DEC / 13
BicalutamidePDL I DEC / 13
Bictegravir or its saltsPDL I AUG / 18
Bilastine or its salts or derivativesPDL I AUG / 16
Biperiden or its saltsPDL I DEC / 13
Bisacodyl when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl U JAN / 14
Bisacodyl and its salts

(except when sold in concentrations of 5mg or less per oral dosage unit or 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)

III JAN / 14
Bishydroxycoumarin or its salts or derivativesPDL I DEC / 13
Bisoprolol or its saltsPDL I DEC / 13
Bitolterol or its saltsPDL I DEC / 13
BivalirudinPDL I DEC / 13
BleomycinPDL I DEC / 13
BlinatumomabPDL I AUG / 16
Boceprevir or its derivativesPDL I DEC / 13
Boric acid and its salts in preparations for systemic use, or ophthalmic preparations in concentrations over 2%[Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion in the eye] II DEC / 98
BortezomibPDL I DEC / 13
Bosentan or its salts or derivativesPDL I DEC / 13
Bosutinib or its saltsPDL

including but not limited to Bosutinib methanoate

I AUG / 14
Botulinum toxinPDL

including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A

I DEC / 13
Brentuximab vedotinPDL I DEC / 13
Bretylium tosylatePDL I DEC / 13
Brexpiprazole or its saltsPDL I APR / 17
Brigatinib or its saltsPDL I AUG / 18
Brimonidine or its saltsPDL I DEC / 13
Brivaracetam or its derivativesPDL I AUG / 16
BrodalumabPDL I MAY / 18
BrolucizumabPDL I JUL / 20
BromalPDL I DEC / 13
Bromal hydratePDL I DEC / 13
BrometonePDL I DEC / 13
Bromfenac or its saltsPDL I MAY / 15
BromisovalPDL I DEC / 13
Bromocriptine or its saltsPDL I DEC / 13
BromoformPDL I DEC / 13
Brompheniramine and its salts as a single entity for the treatment of allergies III JAN / 03
Brompheniramine and its salts. in combination products for the relief of cough and cold symptoms U JAN / 03
Buclizine II SEP / 98
Bufexamac II SEP / 98
Bumetanide or its salts or derivativesPDL I DEC / 13
Bupivacaine and its salts for topical use on mucous membranes except lozenges III SEP / 98
Bupivacaine and its salts for parenteral or ophthalmic use II SEP / 98
Bupropion or its saltsPDL I DEC / 13
BurosumabPDL I DEC / 18
Buserelin or its saltsPDL I DEC / 13
Buspirone or its saltsPDL I DEC / 13
BusulfanPDL I DEC / 13
Butacaine and its salts for ophthalmic or parenteral use II SEP / 98
Butaperazine or its saltsPDL I DEC / 13
Butenafine 1% cream U SEP / 99
Butoconazole or its saltsPDL I DEC / 13
Butorphanol and its salts C I JUN / 02

101 result(s)


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act